{"product_id":"intravenous-set-market-size-share-trends-analysis-global-2024-2030-medcore-includes-pump-sets-secondary-sets-and-2-more","title":"Intravenous Set Market Size, Share \u0026 Trends Analysis-Global-2024-2030-MedCore-Includes: Pump Sets, Secondary Sets, and 2 more","description":"\u003cp\u003eIntravenous Set Market Size, Share \u0026amp; Trends Analysis-Global-2024-2030-MedCore-Includes: Pump Sets, Secondary Sets, and 2 more\u003cbr\u003e\nIn 2023, the worldwide market for intravenous (IV) sets exhibited robust growth, with a total valuation of $6.0 billion, marking a substantial 5.1% increase from the previous year when it stood at $5.7 billion. Projections indicate continued growth momentum throughout the forecast period, with a compound annual growth rate (CAGR) of 4.1%, ultimately reaching an estimated value of $7.9 billion. Notably, the current landscape of the global intravenous set market is predominantly influenced by the presence of two major players, namely Becton Dickinson (BD) and B. Braun.\u003c\/p\u003e\n\n\u003cp\u003eOur extensive medical market research efforts encompassed a comprehensive evaluation of more than 25 intravenous set companies spanning across all seven continents. Employing a rigorous methodology, we delved into various facets of the market, including market sizes, unit sales, company market shares, and generated precise forecasts. The complete report suite dedicated to the global market for intravenous sets encompasses a range of categories, including pump sets, secondary sets, gravity sets, and extension sets.\u003c\/p\u003e\n\n\u003cp\u003eDATA TYPES INCLUDED\u003c\/p\u003e\n\n\u003cp\u003eUnit Sales, Average Selling Prices, Market Value \u0026amp; Growth Trends\u003cbr\u003e\nForecasts Until 2030, and Historical Data to 2020\u003cbr\u003e\nMarket Drivers \u0026amp; Limiters for Each Segment\u003cbr\u003e\nCompetitive Analysis with Market Shares for Each Segment\u003cbr\u003e\nRecent Mergers \u0026amp; Acquisitions\u003cbr\u003e\nCOVID19 Impact\u003cbr\u003e\nDisease Overviews and Demographic Information\u003cbr\u003e\nCompany Profiles, Product Portfolios and SWOT for Top Competitors\u003c\/p\u003e\n\n\u003cp\u003eGLOBAL INTRAVENOUS SET MARKET INSIGHTS\u003c\/p\u003e\n\n\u003cp\u003eWithin the ever-evolving realm of surgical procedures and trauma cases, there is a notable upswing in the demand for intravenous (IV) sets. Whether within the bustling confines of hospital operating rooms or in more mobile ambulatory settings, IV therapy assumes a pivotal role as a lifeline for the controlled administration of fluids and medications with precision. Moreover, in instances of emergent medical scenarios, critical care situations, and traumatic injuries, the immediate and dependable access to veins becomes paramount for the purpose of resuscitation and stabilization. It is within these intense and time-sensitive moments that the requirement for IV sets experiences a significant surge, driven by the indispensable need for consistent vascular access.\u003c\/p\u003e\n\n\u003cp\u003eGLOBAL INTRAVENOUS SET MARKET SHARE INSIGHTS\u003c\/p\u003e\n\n\u003cp\u003eIn the year 2023, Becton Dickinson (BD) emerged as the foremost leader in the global IV set market. BD's entrenched position in various other facets of infusion therapy and related treatment markets over the years played a pivotal role in elevating it to this top-tier status. BD's distinctive advantage lies in its ability to bundle IV sets with a range of complementary products, a strategy that bestows significant benefits upon the company. This approach occasionally empowers BD to offer IV sets in substantial quantities and at a per-set cost that smaller competitors find challenging to match.\u003c\/p\u003e\n\n\u003cp\u003eClaiming the second position in the global IV set market for 2023 was B. Braun. The company exhibited a robust presence in the pump set market, driven by its dominant role in the realm of large-volume infusion pumps. B. Braun held a significant market share in IV sets, particularly in key Western European markets such as Germany and Italy. Beyond Western Europe, the company maintained noteworthy, albeit somewhat smaller, shares in other regions.\u003c\/p\u003e\n\n\u003cp\u003eThe remaining segment of the IV set market remained fragmented, featuring a diverse array of competitors. The relatively modest manufacturing costs associated with IV sets make this sector an attractive space for smaller players to enter. Furthermore, the majority of companies engaged in the production and distribution of infusion pumps also complement their capital products with infusion sets, thereby contributing to the diversity of offerings within the market.\u003c\/p\u003e\n\n\u003cp\u003eMARKET SEGMENTATION SUMMARY\u003c\/p\u003e\n\n\u003cp\u003ePump Set Market – Segmented By:\u003cbr\u003e\nCare Setting: Hospital, Non-Hospital\u003cbr\u003e\nGravity Set Market – Segmented By:\u003cbr\u003e\nHospital, Non-Hospital\u003cbr\u003e\nSecondary Set Market – Segmented By:\u003cbr\u003e\nCare Setting: Hospital, Non-Hospital\u003cbr\u003e\nExtension Set Market – Segmented By:\u003cbr\u003e\nCare Setting: Hospital\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"September, 2023 \/ 73 Pages \/ MCW16247475","offer_id":47670749856050,"sku":null,"price":5994.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/intravenous-set-market-size-share-trends-analysis-global-2024-2030-medcore-includes-pump-sets-secondary-sets-and-2-more","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}